Explore more publications!

Biden’s Cancer Treatment Progress Draws Optimism, Concern

(MENAFN) Former US President Joe Biden has been largely out of the public eye in recent months while receiving treatment for an aggressive form of prostate cancer. Those close to him remain hopeful, describing his condition as manageable, but some longtime friends and allies have privately expressed concern about the physical strain on the 83-year-old, according to reports.

Biden was diagnosed in May 2025 with Stage 4 prostate cancer that had spread to his bones. His aides say he continues to manage the disease through ongoing therapy and remains engaged with projects such as his memoir, plans for his foundation, and his presidential library. A few public appearances are reportedly being planned.

Despite this, several associates, including former officials and Democratic allies, have observed that Biden appears more fatigued in recent weeks. His office has not issued major health updates since last May, when it was disclosed that he was receiving hormone therapy for a hormone-sensitive form of prostate cancer, prompting some concern over the long-term effects of both the illness and its treatment.

Since the diagnosis, Biden has made only a limited number of appearances, mostly at family events, ceremonial functions, and private outings.

MENAFN24022026000045017281ID1110781566


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions